ALBANY, New York, September 2, 2014 /PRNewswire/ --
According to a new market report published "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 is expected to grow at a CAGR of 10.1% from 2014 to 2020.
Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Biological drugs include therapeutic proteins, monoclonal antibody (mAb) and vaccines. The biological drugs market is growing due to the increasing prevalence of chronic diseases and the demand for biological drugs is growing due to the increase in the global geriatric population. Moreover, various government associations are also supporting in growth of biological drugs market. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.
On the other hand, high cost of biologic drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the biological drugs market.
The report provides in-depth analysis and estimation of the biological drugs market from 2014 to 2020, considering 2013 as the base year for calculation. Additionally, data pertaining to current market dynamics including market drivers, restraints, trends and recent developments has been provided in the biological drugs market report. The global biological drugs market is categorized based on therapeutic protein, monoclonal antibody (mAb), vaccine and geography. The therapeutic protein segmentation is further sub-segmented into Enbrel, Lantus, Neulasta, Avonex, NovoLog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, and Eylea. The mAb segment comprises Humira, Remicade, Rituxan, Avastin, Herceptin and Lucentis. The vaccine segment is further sub-segmented into Prevnar 13, Gardasil, Fluzone, Varivax and Cervarix.
Browse Biological Drugs Market Full Report with Toc: http://www.marketresearchreports.biz/analysis-details/biological-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Table of Contents
Chapter 1 Preface
1.1 Report Description
1.2 Research methodology
1.2.1 Sources
Chapter 2 Executive Summary
Chapter 3 Global Biological Drugs Market - Industry Analysis
3.1 Introduction
3.2 Market Drivers
3.3 Market Opportunities
3.4 Restraints
Chapter 4 Market Trends
4.1.1 Increasing use of anti-Vascular Endothelial Growth Factor (VEGF) therapy is gaining popularity in biopharmaceutical industry
4.1.2 Genetically Modified Organisms (GMOs) are gaining importance in biological drugs market
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/177969
Chapter 5 Porter's Five Forces Analysis
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining power of buyers
5.1.3 Threat of new entrants
5.1.4 Threat of substitutes
5.1.5 Degree of competition
Chapter 6 Global Market Size and Forecast
Chapter 7 Segment Analysis, by Therapeutic Protein
Latest and Related Pharmaceutical Market Industry Reports:
The US Specialty Pharmaceutical Market Report: 2013 [http://www.marketresearchreports.biz/analysis/189267]
Specialty pharmaceuticals are defined as a new, rapidly growing drugs and biologics that are manufactured as a result of continued advancements in drug technology and design. These pharmaceuticals are specialized, high cost products which can be difficult to administer and may require patient monitoring. Specialty pharmaceuticals are utilized as complex therapies for complex chronic diseases such as cancer, hemophilia, multiple sclerosis, HIV, hepatitis C, apart from others. Some of the specialized drugs that are used for treating such conditions meet all the three H's: High Cost, High Complexity and High Touch and they require extensive education for safe and cost-effective use. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/189267
Specialty pharmacy is a special class of provider that are primarily responsible for distributing and dispensing the pharmaceutical as specialty pharmaceutical require specialized shipping and temperature-controlled storing and handling. Specialty pharmacy can be owned by stand-alone companies or large pharmacy chains. However, some drug wholesalers are also capable of shipping the specialty pharmaceuticals. There exists a substantial incentive for companies to research and develop products that address the unmet need of the patients as the specialty pharmaceutical market has the ability to sustain the high cost of these products thereby additionally offering a business perspective for the biopharmaceutical companies.
Global Animal Health Market Report: 2013 Edition [http://www.marketresearchreports.biz/analysis/179482]
Animal health market includes pharmaceuticals, vaccines and medicinal feed additives. Pharmaceuticals contribute significantly to the health and well-being of food-producing and companion animals. Food producing animals are the species that provide animal protein including cattle (both beef and dairy), swine, poultry, sheep and fish, whereas companion animals are the animals that are kept by people for companionship, protection and enjoyment such as dogs, cats, and horses among others.
Economic development and the corresponding increases in the disposable income, particularly in the emerging markets of India, China, Indonesia, Thailand, Malaysia, and Taiwan; increasing pet ownership; rising demand for improved nutrition, mainly animal protein; intensifying consumer focus on food safety and the escalating need for greater livestock production efficiency are among the major factors driving the animal health market. The market is projected to further grow in years to come and become more specialized due to economic, social and demographic trends.
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/179482
Global animal health market is consolidated with top eight players controlling by far the majority share of the market. Zoetis, Merck, and Merial are the leading players in the animal health market. Other key players in the market include Elanco, Bayer, Boehringer, Novartis and Virbac.
Surge Protection Devices Market - 2014 - 2020: [http://www.marketresearchreports.biz/analysis/217921]
The concept of protecting electronic devices from power surges or spikes is known as surge protection. Surge protection devices allow multiple components to plug into a single power outlet. A power surge is a significant increase in voltage above the designated level. If power voltage rises above the standard voltage, it is likely to damage the electronic equipment. For instance, the standard voltage in the U.S. and India are 120 volts and 230 volts respectively, in residential and commercial sectors. A surge protector prevents electrical equipment from getting damaged, when the voltage increases beyond the standard level.
The global surge protection devices market is expected to witness a substantial growth during the forecast period. This is due to its increasing demand across various application sectors such as industrial, residential and commercial sectors. Increasing incidences of transient voltage and lightning accidents globally is increasing the usage of surge protection devices. If the surge or spike is high, it can cause heavy damage to electrical equipment.
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/217921
The increase in the usage of electrical equipment such as personal computers, printers and industrial control equipment such as PLC's, microwaves, washing machines and alarms are amplifying the demand for surge protection devices globally.
Among all the application segments, industrial sector holds the largest market share at present in surge protection devices market, whereas; commercial segment is expected to be the fastest growing application segment due to the increase in telephone and internet users in the emerging nations.
For More Latest @:Transparency Market Research Reports
About Us
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. For more information Visit: http://www.marketresearchreports.biz/
Contact us:
Sheela AK
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E-mail: [email protected]
Blog: http://todaysmarketplace.blogspot.com/
SOURCE MarketResearchReports.Biz
Advertisement
According to a new market report published "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 is expected to grow at a CAGR of 10.1% from 2014 to 2020.
Advertisement
Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Biological drugs include therapeutic proteins, monoclonal antibody (mAb) and vaccines. The biological drugs market is growing due to the increasing prevalence of chronic diseases and the demand for biological drugs is growing due to the increase in the global geriatric population. Moreover, various government associations are also supporting in growth of biological drugs market. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.
On the other hand, high cost of biologic drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints of the biological drugs market.
The report provides in-depth analysis and estimation of the biological drugs market from 2014 to 2020, considering 2013 as the base year for calculation. Additionally, data pertaining to current market dynamics including market drivers, restraints, trends and recent developments has been provided in the biological drugs market report. The global biological drugs market is categorized based on therapeutic protein, monoclonal antibody (mAb), vaccine and geography. The therapeutic protein segmentation is further sub-segmented into Enbrel, Lantus, Neulasta, Avonex, NovoLog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, and Eylea. The mAb segment comprises Humira, Remicade, Rituxan, Avastin, Herceptin and Lucentis. The vaccine segment is further sub-segmented into Prevnar 13, Gardasil, Fluzone, Varivax and Cervarix.
Browse Biological Drugs Market Full Report with Toc: http://www.marketresearchreports.biz/analysis-details/biological-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Table of Contents
Chapter 1 Preface
1.1 Report Description
1.2 Research methodology
1.2.1 Sources
Chapter 2 Executive Summary
Chapter 3 Global Biological Drugs Market - Industry Analysis
3.1 Introduction
3.2 Market Drivers
3.3 Market Opportunities
3.4 Restraints
Chapter 4 Market Trends
4.1.1 Increasing use of anti-Vascular Endothelial Growth Factor (VEGF) therapy is gaining popularity in biopharmaceutical industry
4.1.2 Genetically Modified Organisms (GMOs) are gaining importance in biological drugs market
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/177969
Chapter 5 Porter's Five Forces Analysis
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining power of buyers
5.1.3 Threat of new entrants
5.1.4 Threat of substitutes
5.1.5 Degree of competition
Chapter 6 Global Market Size and Forecast
Chapter 7 Segment Analysis, by Therapeutic Protein
Latest and Related Pharmaceutical Market Industry Reports:
The US Specialty Pharmaceutical Market Report: 2013 [http://www.marketresearchreports.biz/analysis/189267]
Specialty pharmaceuticals are defined as a new, rapidly growing drugs and biologics that are manufactured as a result of continued advancements in drug technology and design. These pharmaceuticals are specialized, high cost products which can be difficult to administer and may require patient monitoring. Specialty pharmaceuticals are utilized as complex therapies for complex chronic diseases such as cancer, hemophilia, multiple sclerosis, HIV, hepatitis C, apart from others. Some of the specialized drugs that are used for treating such conditions meet all the three H's: High Cost, High Complexity and High Touch and they require extensive education for safe and cost-effective use. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/189267
Specialty pharmacy is a special class of provider that are primarily responsible for distributing and dispensing the pharmaceutical as specialty pharmaceutical require specialized shipping and temperature-controlled storing and handling. Specialty pharmacy can be owned by stand-alone companies or large pharmacy chains. However, some drug wholesalers are also capable of shipping the specialty pharmaceuticals. There exists a substantial incentive for companies to research and develop products that address the unmet need of the patients as the specialty pharmaceutical market has the ability to sustain the high cost of these products thereby additionally offering a business perspective for the biopharmaceutical companies.
Global Animal Health Market Report: 2013 Edition [http://www.marketresearchreports.biz/analysis/179482]
Animal health market includes pharmaceuticals, vaccines and medicinal feed additives. Pharmaceuticals contribute significantly to the health and well-being of food-producing and companion animals. Food producing animals are the species that provide animal protein including cattle (both beef and dairy), swine, poultry, sheep and fish, whereas companion animals are the animals that are kept by people for companionship, protection and enjoyment such as dogs, cats, and horses among others.
Economic development and the corresponding increases in the disposable income, particularly in the emerging markets of India, China, Indonesia, Thailand, Malaysia, and Taiwan; increasing pet ownership; rising demand for improved nutrition, mainly animal protein; intensifying consumer focus on food safety and the escalating need for greater livestock production efficiency are among the major factors driving the animal health market. The market is projected to further grow in years to come and become more specialized due to economic, social and demographic trends.
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/179482
Global animal health market is consolidated with top eight players controlling by far the majority share of the market. Zoetis, Merck, and Merial are the leading players in the animal health market. Other key players in the market include Elanco, Bayer, Boehringer, Novartis and Virbac.
Surge Protection Devices Market - 2014 - 2020: [http://www.marketresearchreports.biz/analysis/217921]
The concept of protecting electronic devices from power surges or spikes is known as surge protection. Surge protection devices allow multiple components to plug into a single power outlet. A power surge is a significant increase in voltage above the designated level. If power voltage rises above the standard voltage, it is likely to damage the electronic equipment. For instance, the standard voltage in the U.S. and India are 120 volts and 230 volts respectively, in residential and commercial sectors. A surge protector prevents electrical equipment from getting damaged, when the voltage increases beyond the standard level.
The global surge protection devices market is expected to witness a substantial growth during the forecast period. This is due to its increasing demand across various application sectors such as industrial, residential and commercial sectors. Increasing incidences of transient voltage and lightning accidents globally is increasing the usage of surge protection devices. If the surge or spike is high, it can cause heavy damage to electrical equipment.
For Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/217921
The increase in the usage of electrical equipment such as personal computers, printers and industrial control equipment such as PLC's, microwaves, washing machines and alarms are amplifying the demand for surge protection devices globally.
Among all the application segments, industrial sector holds the largest market share at present in surge protection devices market, whereas; commercial segment is expected to be the fastest growing application segment due to the increase in telephone and internet users in the emerging nations.
For More Latest @:Transparency Market Research Reports
About Us
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. For more information Visit: http://www.marketresearchreports.biz/
Contact us:
Sheela AK
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E-mail: [email protected]
Blog: http://todaysmarketplace.blogspot.com/
SOURCE MarketResearchReports.Biz
